Aptorum group Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Aptorum group Contact Number

APTORUM (Nasdaq: APM)

5 hours ago Aptorumgroup.com Show details

Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) is a pharmaceutical company dedicated to developing and commercializing novel therapeutics to tackle unmet medical needs. Aptorum Group is pursuing therapeutic projects in orphan diseases, infectious diseases, metabolic diseases, woman’s health and other disease areas.

Category: Contact NumberShow more

Aptorum Group Crunchbase Company Profile & Funding

3 hours ago Crunchbase.com Show details

44 20 8092

Phone Number +44 20 80929299. Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) is a pharmaceutical company dedicated to the discovery, development and commercializing of therapeutic assets to treat diseases with unmet medical needs, particularly infectious diseases and cancers (including orphan oncology indications).

Founded: 2010

Category: Contact NumberShow more

Aptorum Group Limited (APM) Pharmaceutical Company

4 hours ago Aptoruminfo.com Show details

For more information on Aptorum Group Limited, contact RedChip specialists at: 1-800-REDCHIP (733-2447) Company Overview Aptorum Group Limited (NASDAQ: APM) is a pharmaceutical company dedicated to developing and commercializing novel therapeutics to tackle unmet medical needs.

Category: Contact NumberShow more

Aptorum Group Company Profile Office Locations

Just Now Craft.co Show details

Aptorum Group has 29 Twitter Followers. The number of followers has decreased 6.5% month over month and decreased 4.7% quarter over quarter

Category: Contact NumberShow more

Investor Relations Aptorum Group Limited

8 hours ago Ir.aptorumgroup.com Show details

RSS Feeds. Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) is a pharmaceutical company dedicated to developing and commercializing novel therapeutics to tackle unmet medical needs. Aptorum Group is pursuing therapeutic projects in orphan diseases, infectious diseases, metabolic diseases, woman’s health and other disease areas.

Category: Contact NumberShow more

Aptorum International – Facilitating Life Science

3 hours ago Apmbio.com Show details

Aptorum International Limited is a U.K. subsidiary of the Aptorum Group and is focused on research and development of novel technologies to therapeutics and diagnostics, including infectious diseases. Dedicated to research and development of novel rapid pathogen diagnostics technology for a broad spectrum of infectious diseases.

Category: Contact NumberShow more

SEC Filing Aptorum Group Limited

2 hours ago Ir.aptorumgroup.com Show details

Classification Code Number) (I.R.S. Employer. Identification No.) 17 th Floor to “us,” “our,” “Aptorum,” “we,” the “Company,” the “group” and similar designations refer to Aptorum Group Limited, a Cayman Islands exempted company with limited liability, and its consolidated subsidiaries on or after March 1, 2017

Category: Contact NumberShow more

Aptorum Group LTD Sample Contracts Law Insider

Just Now Lawinsider.com Show details

Aptorum Group LTD – FIRST AMENDMENT TO EXCLUSIVE PATENT LICENSE AGREEMENT. THIS FIRST AMENDMENT TO EXCLUSIVE PATENT LICENSE AGREEMENT (the “Amendment”) is made effective as of 7th June, 2018 by and between Versitech Limited, a company incorporated and existing under the laws of Hong Kong with its office at Room 405A, Cyberport 4, 100 Cyberport Road, Hong …

Category: Contact NumberShow more

Aptorum Group Limited (APM) Company Profile & Facts

4 hours ago Finance.yahoo.com Show details

See the company profile for Aptorum Group Limited (APM) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and

Category: Contact NumberShow more

Maxim Group LLC acts as CoPlacement Agent for …

8 hours ago Maximgrp.com Show details

Aptorum Group Limited (NASDAQ: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, today announced the pricing of a registered direct offering of 1,351,350 Class A ordinary shares and warrants to purchase 1,351,350 of its Class A ordinary shares at an exercise price of $7.40 per … Maxim Group

Category: Contact NumberShow more

Aptorum: developing novel mechanisms for the treatment of

Just Now Nature.com Show details

852 2117 6611

Aptorum Group Limited. Angel Ng, COO, Aptorum Group Limited, Hong Kong, Tel: +852 2117 6611, Website: www.aptorumgroup.com

Category: Contact NumberShow more

Ian Huen – Founder and CEO, Aptorum Group, Hong Kong

8 hours ago Pharmaboardroom.com Show details

Ian Huen, founder and CEO of Aptorum Group, discusses why Hong Kong was the ideal location to base the company, its exciting development pipeline and his unique management philosophy. Ian, with your asset management background, could you share what inspired you to establish Aptorum Group

Category: Contact NumberShow more

Aptorum Group Number of Employees 20182021 APM

9 hours ago Macrotrends.net Show details

Aptorum Group number of employees from 2018 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis

Category: Contact NumberShow more

Aptorum Group Limited to Hold Annual General Meeting of

7 hours ago Us.acrofan.com Show details

Aptorum Group's annual report on Form 20-F can be accessed in the investor section of Aptorum's website at www.aptorumgroup.com, as well as on the SEC's website at www.sec.gov. Shareholders may request a meeting notice, proxy card or hard copy of the annual report on Form 20-F free of charge by contacting [email protected] .

Category: Contact NumberShow more

Aptorum Group Ltd Company Profile and News Bloomberg

8 hours ago Bloomberg.com Show details

Company profile page for Aptorum Group Ltd including stock price, company news, press releases, executives, board members, and contact information

Category: Contact NumberShow more

APTORUM GROUP LIMITED : Shareholders Board Members

2 hours ago Marketscreener.com Show details

Aptorum Group Limited specialises in the research and development of therapeutic products in the fields of neurology, infectious diseases, gastroenterology, oncology, and so on. At the end of 2020, the group had one product in phase I/II clinical development (SACT-1; neuroblastoma treatment) and 6 products in preclinical development (ALS-4, ALS

Category: Contact NumberShow more

Aptorum Group Ltd (APM) 10K Annual Reports & 10Q SEC

5 hours ago Last10k.com Show details

View differences made from one year to another to evaluate Aptorum Group Ltd's financial trajectory Sample 10-K Year-over-Year (YoY) Comparison Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Aptorum Group Ltd.

Category: Contact NumberShow more

Aptorum Group Limited Interview to Air on Bloomberg U.S.

6 hours ago Us.acrofan.com Show details

NEW YORK & LONDON & PARIS--(BUSINESS WIRE)--#biopharmaceutical--Regulatory News:Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM), a clinical stage biopharmaceutical company focused on novel technologies including the targeting of oncological diseases, today announced that an interview with President Darren Lui will air on The RedChip Money …

Category: Contact NumberShow more

SEC.gov HOME

3 hours ago Sec.gov Show details

ex-10.42 3 ff12019ex10-42_aptorum.htm master service agreement between covar pharmaceuticals incorporated and aptorum therapeutics limited dated may …

Category: Home PhoneShow more

Aptorum Group Limited Interview to Air on Bloomberg U.S.

2 hours ago Apnews.com Show details

44 20 8092

CONTACT: Aptorum Group Limited. Investor Relations Department. [email protected] +44 20 80929299Redchip – Financial Communications United States. Investor relations. Dave Gentry. [email protected] +1 407 491 4498Actifin – Financial Communications Europe. Investor relations. Ghislaine Gasparetto. [email protected] +33 1

Category: Contact NumberShow more

Exclusive Interview with President of Aptorum Group YouTube

3 hours ago Youtube.com Show details

Exclusive interview with Aptorum Group Limited (NASDAQ: APM) President Darren Lui. Aptorum is a pharmaceutical company dedicated to developing and commercial

Category: Contact NumberShow more

APM Aptorum Group Ltd. Stock Price & News WSJ

2 hours ago Wsj.com Show details

News Aptorum Group Ltd.APM. No news for in the past two years. The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the

Category: Contact NumberShow more

APTORUM GROUP LIMITED live

3 hours ago Live.euronext.com Show details

Aptorum Group Limited specialises in the research and development of therapeutic products in the fields of neurology, infectious diseases, gastroenterology, oncology, and so on. At the end of 2020, the group had one product in phase I/II clinical development (SACT-1; neuroblastoma treatment) and 6 products in preclinical development (ALS-4, ALS

Category: Contact NumberShow more

Aptorum Group Limited (Nasdaq: APM) :: LD Micro

5 hours ago Ldmicro.com Show details

Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2021. 09/15/2021 08:00 AM EDT. Business Wire. Aptorum Group Limited Has Received IND Clearance From the US FDA to Initiate Clinical Trials for Repurposed Small Molecule Drug SACT-1 for the Treatment of Neuroblastoma. 07/12/2021 08:00 AM EDT.

Category: Contact NumberShow more

Paul Raju Managing Partner Investor Insight Ltd

6 hours ago Uk.linkedin.com Show details

Aptorum Group Limited today is pleased to announce that the French Autorité des Marchés Financiers “AMF” has granted visa number 20-352 on its… Liked by Paul Raju The Government has made up to £617 million available in grants to small and micro businesses …

Title: Managing Partner at Investor …
Location: Greater Cambridge
Connections: 52

Category: Contact NumberShow more

What is Aptorum Valuation? APM Macroaxis

3 hours ago Macroaxis.com Show details

Aptorum Group shows a prevailing Real Value of $2.59 per share. The current price of the firm is $2.59. Based on Macroaxis valuation methodology, the firm appears to be fairly valued.Our model approximates the value of Aptorum Group from analyzing the firm fundamentals such as Shares Outstanding of 13.16 M, return on equity of 18.57 %, and Profit Margin of 775.29 % as well as examining its

Category: Contact NumberShow more

Aptorum Group Collaborates with Covar Pharmaceuticals To

9 hours ago Businesswire.com Show details

Aptorum Group, as part of its existing pipeline, is also developing a number of infectious disease indications under its Acticule platform, including, but not limited to, a unique antiviral small

Category: Contact NumberShow more

Aptorum Group Limited – Revolutionary Woman of the

5 hours ago Theenterpriseworld.com Show details

In conversation with Sabrina Khan CFO of Aptorum Group, which is a clinical-stage biopharmaceutical company, working to provide medical treatments, extensively in the domain of oncology and infectious diseases. Contact Number: +1 …

Category: Contact NumberShow more

Aptorum Group Limited Interview to Air on Bloomberg U.S.

1 hours ago Finance.yahoo.com Show details

NEW YORK & LONDON & PARIS, October 15, 2021--Regulatory News: Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM), a clinical stage biopharmaceutical company focused on novel technologies

Category: Contact NumberShow more

Aptorum Group Limited Interview to Air on Bloomberg U.S

1 hours ago Bakersfield.com Show details

Aptorum Group Limited (NASDAQ: APM, Euronext These forward-looking statements speak only as of the date of this press release and are subject to a number of risks, uncertainties and

Category: Contact NumberShow more

Riko Lam Senior Project Executive MIMS (Hong Kong

4 hours ago Hk.linkedin.com Show details

Activity. A clear path to increasing women’s power and influence in the United States is to elect more women to public office. A record number of women are…. Liked by Riko Lam. FDA has granted an emergency use authorization for an outpatient therapy to treat mild to moderate #COVID19. The monoclonal antibody, bamlanivimab….

Title: Senior Project Executive at MIMS …
Location: Hong Kong
Connections: 73

Category: Contact NumberShow more

Aptorum Group Prospectus Receives Approval for Listing on

9 hours ago Nasdaq.com Show details

Aptorum Group Limited, a biopharmaceutical company focusing on the development of novel therapeutics to address global unmet medical needs, …

Category: Contact NumberShow more

Aptorum Group Becomes the First Nasdaq Listed

Just Now Nasdaq.com Show details

Aptorum Group’s current drug pipeline includes indications in orphan diseases, infectious diseases and metabolic diseases, a number of which are targeted to enter clinical trial phases.

Category: Contact NumberShow more

Aptorum Group Announces Closing of $9.0 Million Public

5 hours ago Biospace.com Show details

NEW YORK & LONDON & PARIS--(BUSINESS WIRE)-- Aptorum Group Limited (Nasdaq:APM, Euronext Paris:APM) (“Aptorum Group” or “Aptorum”), a biopharmaceutical company focused on novel technologies including the targeting of infectious diseases, today announced the closing of a public offering of 2,769,231 Aptorum’s Class A ordinary shares (or ordinary share equivalents) …

Category: Contact NumberShow more

APTORUM GROUP LIMITED : APM Stock Price KYG6096M1069

4 hours ago Marketscreener.com Show details

Company. Aptorum Group Limited specialises in the research and development of therapeutic products in the fields of neurology, infectious diseases, gastroenterology, oncology, and so on. At the end of 2020, the group had one product in phase I/II clinical development (SACT-1; neuroblastoma treatment) and 6 products in preclinical development

Category: Contact NumberShow more

Aptorum Group (NasdaqGM:APM) Share price, News

Just Now Simplywall.st Show details

Aptorum Group Limited Announces Further Positive Interim Results of the Phase 1 Clinical Trial of ALS-4 Targeting Staphylococcus Aureus. Aptorum Group Limited announced further positive results of its ongoing Phase 1 clinical trial for ALS-4 (a first in-class anti-virulence approach based small molecule targeting Staphylococcus aureus, including, but not limited to Methicillin …

Category: Contact NumberShow more

Sabrina Khan Pharmcist H.A.MCPARLAND LIMITED LinkedIn

9 hours ago Uk.linkedin.com Show details

View Sabrina Khan’s profile on LinkedIn, the world’s largest professional community. Sabrina has 1 job listed on their profile. See the complete profile on LinkedIn and discover Sabrina’s connections and jobs at similar companies.

Title: Pharmcist at H.A.MCPARLAND …
Location: Enfield, England, United Kingdom
Connections: 86

Category: Contact NumberShow more

Peggy Leung Operations Manager Talem Medical Group

5 hours ago Hk.linkedin.com Show details

Operation Manager, Aptorum Therapeutics Limited. Aptorum Group Limited. Feb 2019 - Nov 20201 year 10 months. Hong Kong.

Title: Operations Manager at Talem …
Location: Hong Kong SAR
Connections: 367

Category: Contact NumberShow more

APM Aptorum Group Ltd Cl A Stock Interactive Chart

Just Now Barchart.com Show details

The number of points the security must move before a new brick is formed. Column : Much like Line and Area charts, a Column chart plots a vertical bar for the close. High/Low Price Markers: Charts are designed to indicate the high and low bars for the visible data range using a small "arc" on two bars:

Category: Contact NumberShow more

Aptorum Group Limited (NASDAQ: APM) Webcast SNN Network

3 hours ago Youtube.com Show details

Aptorum Group Limited (NASDAQ: APM) Full webcast at the Planet MicroCap Showcase Virtual Investor Conference 2020.For more information about Aptorum Group Li

Category: Contact NumberShow more

Report of Foreign Issuer Pursuant to Rule 13a16 or 15d16

3 hours ago Ih.advfn.com Show details

Commission File Number: 001-38764 . Aptorum Group Limited. 17 Hanover Square, London, W1S 1BN. United Kingdom (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under …

Category: Contact NumberShow more

Aptorum Group PE Ratio 20182021 APM MacroTrends

8 hours ago Macrotrends.net Show details

Current and historical p/e ratio for Aptorum Group (APM) from 2018 to 2021. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure.

Category: Contact NumberShow more

Aptorum Group Limited Interview to Air on Bloomberg U.S.

4 hours ago Sharewise.com Show details

Regulatory News: Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM), a clinical stage biopharmaceutical company focused on novel technologies including the targeting of oncological diseases, today announced that an interview with President Darren Lui will air on The RedChip Money Report ® on Bloomberg TV Oct. 16 at 7 p.m. Eastern Time (ET).. To view the …

Category: Contact NumberShow more

Aptorum Group Ltd (APM) Price Targets From Analysts

5 hours ago Stocknews.com Show details

Aptorum Group Ltd's number of analysts covering the stock is greater than nearly none of all US stocks. APM has a lower variance in analysts' estimates than just about 100% of all US stocks. Aptorum Group Ltd's upside potential (average analyst target price relative to …

Category: Contact NumberShow more

Aptorum Group Limited Interview to Air on Bloomberg U.S

4 hours ago Businesswire.com Show details

44 20 8092

Contacts. Aptorum Group Limited Investor Relations Department [email protected] +44 20 80929299 Redchip – Financial Communications United States Investor relations Dave Gentry

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Popular Brands

Amazon
Abbvie
Aia
Asml
Apple
Att
Amgen
Adobe
Aptar
Acc
Adidas
Aak
Aes
Asx